Silent Trypanosoma evansi infection in humans from India revealed by serological and molecular surveys, and characterized by variable surface glycoprotein gene sequences

Acta Trop. 2022 May:229:106369. doi: 10.1016/j.actatropica.2022.106369. Epub 2022 Feb 12.

Abstract

Background: The importance of emerging atypical human trypanosomosis is gaining momentum due to increasing detection and its possible impact on human health. A cross sectional study of atypical human trypanosomosis due to Trypanosoma evansi was carried out in Kolkata and Canning area of West Bengal state of India where previously a death was reported.

Methods: In this study blood and serum samples from 173 individuals were collected during August to December 2014. To check the presence of antibodies against T. evansi, card agglutination test and for the presence of T. evansi specific DNA, PCR were conducted.

Results: T. evansi infection was identified in 5.2% (9/173) human blood samples by CATT serological test (Card agglutination test for trypanosomosis). PCR targeting VSG gene sequences suggested active T. evansi infection in 2.89% (5/173). VSG gene sequences herein determined for five isolates from human cases shared high similarity (89.4-100%). Phylogenetic inference clustered the human isolates with other isolates from different host species from India and other countries, forming a clade exclusive of Indian isolates (84.0 to 100% sequence similarity).

Conclusion: First report of symptomless human T. evansi infection detected by combined serological and PCR assays. First phylogenetic analysis of VSG gene sequences including human isolates of T. evansi in which Indian isolates of T. evansi from human and other hosts clustered in a single clade.

Keywords: Antibodies; Human; Silent infection; Trypanosoma evansi; Variable surface glycoprotein gene.

MeSH terms

  • Cross-Sectional Studies
  • Humans
  • Membrane Glycoproteins / genetics
  • Phylogeny
  • Trypanosoma*
  • Trypanosomiasis* / epidemiology

Substances

  • Membrane Glycoproteins